Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-157.62%EBIT Margin
VS
Market
Sector
Industry
History
$ 2.12Close
$ 1.86 - $ 7.1 52-Week Range
Ticker Information
Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINMED PHARMACEUTICALS INC - EBIT Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INM - EBIT % Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -7.79M | -157.62% | $ 4.94M |
| 3/31/2025 | $ -7.95M | -161.61% | $ 4.92M |
| 12/31/2024 | $ -7.55M | -156.35% | $ 4.83M |
| 9/30/2024 | $ -6.81M | -137.27% | $ 4.96M |
| 6/30/2024 | $ -7.67M | -166.79% | $ 4.6M |
| 3/31/2024 | $ -6.07M | -107.98% | $ 5.63M |
| 12/31/2023 | $ -6.35M | -115.69% | $ 5.49M |
| 9/30/2023 | $ -6.97M | -147.73% | $ 4.72M |
| 6/30/2023 | $ -7.93M | -191.86% | $ 4.14M |
| 3/31/2023 | $ -15.47M | -661.23% | $ 2.34M |
Key Performance Insights, Last 5 Years
- INMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
- Over the past 5 years, INMED PHARMACEUTICALS INC's average EBIT % has been -912.5%.
- The median EBIT % for INMED PHARMACEUTICALS INC during this period was -166.79%
- INMED PHARMACEUTICALS INC reached its highest EBIT % over the past 5 years at -107.98%.
- The lowest EBIT % recorded by INMED PHARMACEUTICALS INC in the same timeframe -5135.82%
INMED PHARMACEUTICALS INC's EBIT % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT % Benchmarks
Similar metrics to Revenues:
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
Definition of EBIT Margin
[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.EBIT / Revenues
(=) EBIT % EBIT % for INMED PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -9.84M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ] INM - EBIT Margin, Last 5 years
-5135.82%
Minimum
Dec 31, 2021
-107.98%
Maximum
Mar 31, 2024
-912.5%
Average
-166.79%
Median
EBIT % Benchmark AnalysisMarket
The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
| filtered constituents | 3.26K |
|---|---|
| min | -73.16% |
| max | 83.08% |
| average | 9.55% |
| median | 9.01% |
| std | 23.96% |